Loomis, Sayles & Company
VRTX icon

Loomis, Sayles & Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.7B Buy
3,813,378
+65,047
+2% +$29M 2.13% 14
2025
Q1
$1.82B Sell
3,748,331
-24,458
-0.6% -$11.9M 2.63% 11
2024
Q4
$1.52B Buy
3,772,789
+704,575
+23% +$284M 1.92% 15
2024
Q3
$1.43B Sell
3,068,214
-73,957
-2% -$34.4M 1.87% 13
2024
Q2
$1.47B Buy
3,142,171
+31,743
+1% +$14.9M 2.03% 14
2024
Q1
$1.3B Sell
3,110,428
-24,424
-0.8% -$10.2M 1.85% 15
2023
Q4
$1.28B Sell
3,134,852
-28,616
-0.9% -$11.6M 1.95% 15
2023
Q3
$1.1B Sell
3,163,468
-111,842
-3% -$38.9M 1.89% 15
2023
Q2
$1.15B Sell
3,275,310
-96,336
-3% -$33.9M 1.86% 14
2023
Q1
$1.06B Sell
3,371,646
-387,524
-10% -$122M 1.84% 16
2022
Q4
$1.09B Sell
3,759,170
-399,220
-10% -$115M 2.17% 13
2022
Q3
$1.2B Sell
4,158,390
-299,346
-7% -$86.7M 2.44% 14
2022
Q2
$1.26B Sell
4,457,736
-1,931,287
-30% -$544M 2.33% 14
2022
Q1
$1.67B Sell
6,389,023
-246,230
-4% -$64.3M 2.23% 15
2021
Q4
$1.46B Sell
6,635,253
-370,739
-5% -$81.4M 1.76% 19
2021
Q3
$1.27B Buy
7,005,992
+4,955,119
+242% +$899M 1.56% 21
2021
Q2
$414M Buy
2,050,873
+2,049,877
+205,811% +$413M 0.5% 36
2021
Q1
$214K Buy
996
+810
+435% +$174K ﹤0.01% 500
2020
Q4
$44K Sell
186
-440
-70% -$104K ﹤0.01% 549
2020
Q3
$170K Buy
626
+159
+34% +$43.2K ﹤0.01% 513
2020
Q2
$136K Sell
467
-41
-8% -$11.9K ﹤0.01% 514
2020
Q1
$121K Buy
508
+26
+5% +$6.19K ﹤0.01% 525
2019
Q4
$106K Buy
+482
New +$106K ﹤0.01% 574
2014
Q3
Sell
-3,036,552
Closed -$288M 749
2014
Q2
$288M Sell
3,036,552
-423,328
-12% -$40.1M 0.82% 22
2014
Q1
$245M Sell
3,459,880
-294,353
-8% -$20.8M 0.69% 28
2013
Q4
$279M Hold
3,754,233
0.84% 19
2013
Q3
$285M Sell
3,754,233
-229,086
-6% -$17.4M 0.92% 17
2013
Q2
$318K Buy
+3,983,319
New +$318K 1.13% 13